172. 低ホスファターゼ症 Hypophosphatasia Clinical trials / Disease details

臨床試験数 : 34 / 薬物数 : 19 - (DrugBank : 4) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 6

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04980248 (ClinicalTrials.gov)	July 22, 2021	23/7/2021	Study of ALXN1850 in Participants With Hypophosphatasia (HPP)	A Phase 1, Open-label, Dose-escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, ...	Hypophosphatasia	Biological: ALXN1850	Alexion Pharmaceuticals	NULL	Recruiting	18 Years	N/A	All	15	Phase 1	United States